Drug intelligence / Profile preview

cathepsin S siRNA

Development stage
Unknown
Lead developer
The First Affiliated Hospital of Guangxi Medical University
Modality
Chemically Modified siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Conjugated siRNA → Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
01

Overview

Cathepsin S siRNA (also referred to as CatS siRNA) is an investigational small interfering RNA (siRNA) therapeutic designed to target and silence the expression of cathepsin S (CTSS). Cathepsin S is a lysosomal cysteine protease that plays a critical role in the degradation of the extracellular matrix, facilitating tumor invasion, metastasis, and angiogenesis. By utilizing RNA interference (RNAi) to knock down cathepsin S expression, this agent aims to inhibit tumor growth, invasion, and angiogenesis. It has been explored in early-stage clinical research (Phase 1) by the First Affiliated Hospital of Guangxi Medical University for the treatment of hepatocellular carcinoma (liver cancer).

Other names
CatS siRNACTSS siRNAcathepsin S small interfering RNA
02

Targets

CTSS (Cathepsin S)

Beyond the preview

Go deeper on cathepsin S siRNA.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on cathepsin S siRNA.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call